United States· US:70700-173_4b807769-4cf0-f110-e063-6294a90ac6a7

Tobramycin

A tobramycin product containing tobramycin sulfate, registered in United States by Xiromed LLC. The same ATC class is registered in 15 of our 19 countries.

ATC J01GB01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTobramycinATCJ01GB01REGISTER NO.US:70700-173_4b807769…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Tobramycin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01GB01 (tobramycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Tobramycin · ATC J01GB01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tobramycin costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tobramycin · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$98.67
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TOBRAMYCIN SULFATE
Manufacturer
Xiromed LLC
Country
United States (US)
ATC code
J01GB01
ATC class
Tobramycin
Defined daily dose
0.3 g, Inhal
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    7070017322
    1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE
  • ndc11
    7070017386
    6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-86) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE
  • ndc11
    70700-173-22
  • ndc11
    70700-173-86

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

191 interactions on record for tobramycin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tobramycin · interactions on record

191 records

  • 29 severe
  • 62 moderate
  • 2 minor
  • 98 info

Most severe, free to view

  • Magnesium sulfateA06AD04severe
  • MannitolA06AD16severe
  • Polymyxin BA07AA05severe
  • Magnesium sulfateA12CC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tobramycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tobramycin products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Bramitob, Tobi
  • Belgium · Obracin, Tobi
  • Bulgaria · Tобрекс, Тобрамизил
  • Cyprus · Bramitob, Ikobel
  • Czechia · Bramitob, Tobramycin Vioser
  • Germany · Bramitob, Gernebcin
  • Denmark · Nebcina, Tobi
  • Estonia · Tobramycin Via Pharma, Tobrex
  • Spain · Bramitob, Tobrabact
  • Finland · Tobi
  • France · Nebcine, Tobi
  • United Kingdom (Northern Ireland) · Bramitob, Munuza
  • Greece · Bramitob, Eyetobrin
  • Croatia · Bramitob, Tobrex
  • Hungary · Bramitob, Brulamycin
  • Ireland · Bramitob, Tobi
  • Iceland · Tobi Podhaler, Vantobra
  • Italy · Bramicil, Bramitob
  • Liechtenstein · Tobi Podhaler, Vantobra
  • Lithuania · Bramitob, Tobramycin Via Pharma
  • Luxembourg · Obracin, Tobi
  • Latvia · Bramitob, Tobramycin Via Pharma
  • Malta · Tobi, Tobrex
  • Netherlands · Bramitob, Obracin
  • Norway · Bramitob, Nebcina
  • Poland · Bramitob, Tobramycin Via Pharma
  • Portugal · Bramitob, Tobi
  • Romania · Tobi, Tobramicină Sun
  • Sweden · Bramitob, Nebcina
  • Slovenia · Tobrex
  • Slovakia · Bramitob, Tobrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d20ca74c-b867-4c5b-b0a4-2f12aa2768e6
GET /v1/drugs/d20ca74c-b867-4c5b-b0a4-2f12aa2768e6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1.2",
  "substance": "TOBRAMYCIN SULFATE",
  "productndc": "70700-173",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/30mL",
  "application_number": "ANDA211189",
  "marketing_category": "ANDA"
}

See everything about tobramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.